Nutriband Inc. (NTRB): Price and Financial Metrics
NTRB Price/Volume Stats
| Current price | $4.11 | 52-week high | $9.60 |
| Prev. close | $4.07 | 52-week low | $2.22 |
| Day low | $4.09 | Volume | 6,000 |
| Day high | $4.22 | Avg. volume | 19,836 |
| 50-day MA | $4.54 | Dividend yield | N/A |
| 200-day MA | $5.20 | Market Cap | 45.65M |
NTRB Stock Price Chart Interactive Chart >
Nutriband Inc. (NTRB) Company Bio
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida
NTRB Price Returns
| 1-mo | 0.74% |
| 3-mo | -29.38% |
| 6-mo | -55.57% |
| 1-year | 55.39% |
| 3-year | -15.26% |
| 5-year | -69.56% |
| YTD | -12.74% |
| 2024 | 103.02% |
| 2023 | -35.64% |
| 2022 | -64.24% |
| 2021 | -32.80% |
| 2020 | N/A |
Loading social stream, please wait...